Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v3.6.0.2
Consolidated Financial Statement Detail (Tables)
 12 Months Ended
Dec. 31, 2016
Consolidated Financial Statement Detail [Abstract]  
Trade and Other Receivables

Trade and other receivables consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Trade receivables, net

 

$

474

 

 

$

3,718

 

Other receivables

 

 

92

 

 

 

351

 

Total

 

$

566

 

 

$

4,069

 

 
Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Equipment and furniture

 

$

14,023

 

 

$

14,431

 

Leasehold improvements

 

 

554

 

 

 

2,776

 

Construction-in-progress

 

 

—

 

 

 

243

 

 

 

 

14,577

 

 

 

17,450

 

Less:  Accumulated depreciation and amortization

 

 

(13,541

)

 

 

(15,453

)

Property and equipment, net

 

$

1,036

 

 

$

1,997

 

 
Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Accrued payroll and other benefits

 

$

1,582

 

 

$

2,156

 

Accrued legal and accounting fees

 

 

385

 

 

 

517

 

Accrued clinical trial costs

 

 

743

 

 

 

406

 

Accrued incentive compensation

 

 

—

 

 

 

2,609

 

Other

 

 

1,505

 

 

 

878

 

Total

 

$

4,215

 

 

$

6,566